VERVANIS
LIVE

Serial Number

79132964

Owner

Provensis Limited

Filing Date

Oct 3, 2012

Add to watchlist:

No watchlists yet
View on USPTO

VERVANIS Trademark

Serial Number: 79132964 • Registration: 4565946

VERVANIS is a trademark filed by Provensis Limited on October 3, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Provensis Limited (15 trademarks)

5 Fleet Place

Entity Type: 99

Trademark Details

Filing Date

October 3, 2012

Registration Date

July 15, 2014

Published for Opposition

April 29, 2014

Cancellation Date

October 4, 2022

Goods & Services

Pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; sterilizing preparations

Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the manufacture of injectable foams

Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical evaluation of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical treatment of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical services provided to post-treatment and homecare patients in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; providing outpatient medical services regarding the administering of medications and therapy in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment

Needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical or medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions

Scientific research services related to sclerotherapy of veins including research relating to provision of treatment in the fields of phlebology, proctology and angiology

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Apr 23, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 23, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 20, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 19, 2022 INTS
INVALIDATION PROCESSED
Feb 19, 2022 INPC
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2022 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Oct 13, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 15, 2015 FICS
FINAL DISPOSITION PROCESSED
Jan 15, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 15, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2014 R.PR
PUBLISHED FOR OPPOSITION
Apr 29, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Apr 25, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 9, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 9, 2014 OP2R
NOTICE OF PUBLICATION
Apr 9, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 26, 2014 PREV
ASSIGNED TO LIE
Mar 26, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2014 TROA
REFUSAL PROCESSED BY IB
Sep 1, 2013 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 12, 2013 RFCS
REFUSAL PROCESSED BY MPU
Aug 12, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 9, 2013 RFCR
NON-FINAL ACTION WRITTEN
Aug 8, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 31, 2013 MAFR
ASSIGNED TO EXAMINER
Jul 27, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 26, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2013 REPR